1. Your personal details 1.1 First Name: 1.2 Last Name: 1.3 Organisation: 1.4 Country: Select... Afghanistan Albania Algeria Andorra Angola Antigua and Barbuda Argentina Armenia Australia Austria Azerbaijan Bahamas Bahrain Bangladesh Barbados Belarus Belgium Belize Benin Bhutan Bolivia Bosnia and Herzegovina Botswana Brazil Brunei Bulgaria Burkina Faso Burundi Cambodia Cameroon Canada Cape Verde Central African Republic Chad Chile China Colombi Comoros Congo (Brazzaville) Congo Costa Rica Cote d'Ivoire Croatia Cuba Cyprus Czech Republic Denmark Djibouti Dominica Dominican Republic East Timor (Timor Timur) Ecuador Egypt El Salvador Equatorial Guinea Eritrea Estonia Ethiopia Fiji Finland France Gabon Gambia, The Georgia Germany Ghana Greece Grenada Guatemala Guinea Guinea-Bissau Guyana Haiti Honduras Hungary Iceland India Indonesia Iran Iraq Ireland Israel Italy Jamaica Japan Jordan Kazakhstan Kenya Kiribati Korea, North Korea, South Kuwait Kyrgyzstan Laos Latvia Lebanon Lesotho Liberia Libya Liechtenstein Lithuania Luxembourg Macedonia Madagascar Malawi Malaysia Maldives Mali Malta Marshall Islands Mauritania Mauritius Mexico Micronesia Moldova Monaco Mongolia Morocco Mozambique Myanmar Namibia Nauru Nepa Netherlands New Zealand Nicaragua Niger Nigeria Norway Oman Pakistan Palau Panama Papua New Guinea Paraguay Peru Philippines Poland Portugal Qatar Romania Russia Rwanda Saint Kitts and Nevis Saint Lucia Saint Vincent Samoa San Marino Sao Tome and Principe Saudi Arabia Senegal Serbia and Montenegro Seychelles Sierra Leone Singapore Slovakia Slovenia Solomon Islands Somalia South Africa Spain Sri Lanka Sudan Suriname Swaziland Sweden Switzerland Syria Taiwan Tajikistan Tanzania Thailand Togo Tonga Trinidad and Tobago Tunisia Turkey Turkmenistan Tuvalu Uganda Ukraine United Arab Emirates United Kingdom United States Uruguay Uzbekistan Vanuatu Vatican City Venezuela Vietnam Yemen Zambia Zimbabwe 1.5 Email: 2. Your organisation's main field of interest

• Business Production Retail Insurance and Finance Industrial and Professional Organisation
• Environmental Health & Safety (EHS) and/or Ethical, Legal & Social Issues (ELSI) EHS / ELSI
• Research Academia Industry
• Regulatory and Control Governance or policymaking Regulatory agency or standards organisation Legal
• People NGO Consumer association Social/Ethical researcher Workers organisation
• Other Other:

3. In relation to the Environmental Health & Safety (EHS) issues associated with nanotechnology, please indicate on a scale of 1 (not important) to 5 (extremely important) the value you would attribute to the following factors

• Hazard identification 1 2 3 4 5
• Information on exposure routes 1 2 3 4 5
• Risk assessment 1 2 3 4 5
• Risk management processes 1 2 3 4 5
• Availability of safety data e.g. under REACH 1 2 3 4 5
• Availability of means of characterisation of nanomaterials 1 2 3 4 5
• Availability of standardised test methods 1 2 3 4 5
• Standardised nanotechnology nomenclature 1 2 3 4 5
• Labelling of nanomaterials and nano-products along their life-cycle 1 2 3 4 5
• Safey in the laboratory 1 2 3 4 5
• Safety in manufacturing 1 2 3 4 5
• Product safety testing 1 2 3 4 5
• End of life (waste stream) issues 1 2 3 4 5
• Release of nanomaterials into the environment 1 2 3 4 5
• Public perceptions of safety 1 2 3 4 5
• Please elaborate on your answers if necessary:

4. Do you believe that current legislation adequately addresses the needs of nanotechnology:

• in your own country?Yes No Partially Don't know
• in the EU?Yes No Partially Don't know

4.1 As you answered 'No' or 'Partially' in question 4, please complete the following as applicable

• Insufficient in terms of scope
• Insufficient in terms of safety
• Insufficient in terms of guidance for implementation
• Current provisions are not suitable in terms of addressing nanotechnology
• The provisions are liable to restrict innovation
• Other:

5. Do you believe that there are materials/products or clas of products using nanotechnology for which existing legislation is certainly not adequate?

• Chemicals and materials
• Cosmetics
• Foods and feeds
• Medicinal products i.e. pharmaceuticals
• Medical devices
• Occupational safety
• Environmental protection
• Other:

6. Do you think the responsible development of nanotechnology would be best addressed by

• new legislation Yes No Don't know
• extension/adaptation of existing legislationYes No Don't know
• voluntary measures and codes of practiceYes No Don't know
• a combination of legislation and voluntary measures e.g. standards/codes of practiceYes No Don't know
• other:

7. In relation to voluntary measures, do you agree with the following:

• They are an opportunity to increase safety and trust among stakeholders Yes No Don't know
• Would be effective only if rewards or penalties are applied Yes No Don't know
• Would put an additional economic pressure on business Yes No Don't know
• Voluntary measures hinder or delay the development of mandatory regulation Yes No Don't know
• Current methodologies e.g. risk assessment procedures and other tools e.g. standardised nanotechnology definitions, are not adequate to support voluntary measures Yes No Don't know

8. Do you think the regulation of nanotechnology should be addressed by

• National legislation?Yes No Don't know
• EU legislation?Yes No Don't know
• Supranational, international legislation?Yes No Don't know

9. In your opinion which authorities should regulate nanotechnology?

• Existing national authorities / regulatory bodies
• New national authorities dedicated to nanotechnology
• New international authorities dedicated to nanotechnology
• Other:

10. Please indicate on the scale of 1 (not important) to 5 (extremely important) the value you would attribute to each of the following principles in terms of their importance to the governance of nanotechnology

• Precautionary principle 1 2 3 4 5
• Inclusiveness 1 2 3 4 5
• Flexibility 1 2 3 4 5
• Scientific integrity 1 2 3 4 5
• Meaning 1 2 3 4 5
• Excellence 1 2 3 4 5
• Innovation 1 2 3 4 5
• Ability to adapt to/promote innovation 1 2 3 4 5
• Ability to promote self-regulation 1 2 3 4 5
• Transparency 1 2 3 4 5
• Openness 1 2 3 4 5
• Public safety 1 2 3 4 5
• Health and safety at work 1 2 3 4 5
• Environmental protection 1 2 3 4 5
• Maintaining the quality of science 1 2 3 4 5
• The protection of intellectual property 1 2 3 4 5
• Sustainability 1 2 3 4 5
• Responsibility 1 2 3 4 5
• Accountability 1 2 3 4 5
• Providing legal certainty 1 2 3 4 5

11. The following have been suggested in a recent European forum as being important to nanotechnology governance in Europe. Please indicate on a scale from 1 (do not agree) to 5 (strongly agree) the level to which you agree or disagree
The inclusion of transformative policies to

• encourage investment in nanotechnology development 1 2 3 4 5
• support the competitiveness of industry 1 2 3 4 5
• encourage excellence in nanoscience and nanotechnology research 1 2 3 4 5
• facilitate education in nanotechnology 1 2 3 4 5
• provide transformative tools 1 2 3 4 5

Responsible development

• in terms of environment, health and safety (EHS) issues 1 2 3 4 5
• in terms of ethical, legal and social issues (ELSI) 1 2 3 4 5
• the development of methods/tools to support risk governance 1 2 3 4 5
• providing a suitable framework for oversight 1 2 3 4 5
• the means to support the participation of key stakeholders 1 2 3 4 5
• providing suitable tools for communication 1 2 3 4 5

A visionary view

• taking a global perspective of nanotechnology development 1 2 3 4 5
• long-term planning in relation to societal needs 1 2 3 4 5
• relating nanotechnology to human development 1 2 3 4 5

Inclusion and collaboration

• societal engagement 1 2 3 4 5
• at national level 1 2 3 4 5
• at European level 1 2 3 4 5
• at international level 1 2 3 4 5

12. In relation to the ethical, legal and social issues (ELSI) associated with nanotechnology, please indicate whether or not you agree that nanotechnology

• will have an overall positive impact on society Yes No Don't know
• will revolutionise manufacturing Yes No Don't know
• will make an important contribution to the future economy Yes No Don't know
• will benefit all levels of society Yes No Don't know
• can help contribute towards a fairer society Yes No Don't know
• will have negative consequences for the labour market Yes No Don't know
• can contribute positively towards third world country development Yes No Don't know
• has the potential to destabilise society Yes No Don't know
• has the potential to affect international relations Yes No Don't know
• raises important ethical questions for society Yes No Don't know
• could obscure distinctions between life and non-life Yes No Don't know
• has the potential for serious misuse e.g. criminal, military Yes No Don't know
• Please elaborate on your answers if necessary:

13. In relation with ELSI associated with nanotechnology, please indicate on a scale of 1 (not important) to 5 (extremely important) the value you would attribute to the following ethical issues

• Non therapeutic human enhancement and novel (medical) applications exploring man-machine interactions (e.g. ICT brain implants, augmentation of senses etc) 1 2 3 4 5
• Increased personal responsibility related to novel diagnostic tools providing predictive information on diseases (predictive medicine) 1 2 3 4 5
• Protection of personal data, privacy, limits to personal freedom, raised by novel surveillance, military and medical applications of nanotechnology 1 2 3 4 5
• Non discrimination in the access to the benefits of nanotechnology, raising of a 'nanotechnology divide' with the developing world 1 2 3 4 5
• Rights to access information, in relation to the use of intellectual property rights 1 2 3 4 5
• Use/misuse of novel applications in criminal or terrorist activities 1 2 3 4 5
• Please elaborate on your answers if necessary:

14. In relation with societal engagement in the governance of nanotechnology, please indicate on a scale of 1 (not important) to 5 (extremely important) the value you would attribute to the following factors

• No need for any specific communication action for nanotechnology 1 2 3 4 5
• Improve risk communication to avoid negative risk perception for nanotechnology 1 2 3 4 5
• Helping to make available to the public a range of scientifically informed opinions of the technology i.e. pros and cons 1 2 3 4 5
• Making available to the public clear and transparent descriptions of the approach to regulation and funding, anticipating benefits, costs, risks and uncertainties 1 2 3 4 5
• Making available to the public information on who has the responsibility to regulate and support nanotechnology 1 2 3 4 5
• Informed and concerned stakeholders should contribute to the direction of research and development on nanotechnology 1 2 3 4 5
• Public trust in the ability of public bodies to regulate nanotechnology for the good of society 1 2 3 4 5
• Please elaborate on your answers if necessary:

15. Please indicate, on a scale of 1 to 5 (where 1 represents no barrier at all and 5 represents a major barrier) your estimation of which of the following constitute a barrier to the responsible development of nanotechnology

• Lack of regulatory framework 1 2 3 4 5
• Inability of regulation to keep pace with scientific discovery/development 1 2 3 4 5
• Lack of agreed common risk management methodologies (including risk assessment) 1 2 3 4 5
• Lack of knowledge concerning nanotechnology risks 1 2 3 4 5
• Lack of standards or other voluntary tools 1 2 3 4 5
• Lack of knowledge of the sector amongst those responsible for its governance 1 2 3 4 5
• Lack of societal engagement 1 2 3 4 5
• Lack of investment 1 2 3 4 5
• Lack of education about nanotechnology 1 2 3 4 5
• Public perception issues 1 2 3 4 5
• Communication issues e.g. press misunderstandings 1 2 3 4 5
• Differences in perspective and opinion between different societal stakeholders 1 2 3 4 5

16. Please add any additional comments regarding your views on the needs and requirements in nanotechnology governance 17. Please add the title(s) and reference(s) of any governance models that you consider particulary relevant to nanotechnology 18. Any additional comments not covered by the above: 19. Were you aware of the European Commission Recommendation on a code of conduct for responsible nanosciences and nanotechnologies research (CoC) prior to completing this questionnaire? http://ec.europa.eu/nanotechnology/pdf/nanocode-rec_pe0894c_en.pdf Yes No 20. What action(s) will your company/organisation take in respect of the principles and recommendations of the EC Recommendations on a CoC mentioned in question 19?

• Follow the CoC Yes No Don't know
• Adapt the provisions of the CoC to your organisation’s needs? Yes No Don't know
• Prepare for the implementation of the CoC? Yes No Don't know
• Try to find specialist help to improve implementation of the CoC? Yes No Don't know
• Share good practices as described in the CoC? Yes No Don't know
• Other? (please specify)